Middle East Pharmaceutical Industries Company engages in the research, development, manufacture, and marketing of generic medicines and pharmaceutical preparations in the Kingdom of Saudi Arabia and internationally. The company operates through three segments: Private, Public, and Export. Its product portfolio includes dermatological, respiratory, cardiovascular, alimentary and anti-infective, mus...
Middle East Pharmaceutical Industries reported revenue of 460.48 million SAR for fiscal year 2025, and net income of 97.01 million SAR. Its largest business segment, Private Customers, brought in 67% of segment revenue in fiscal year 2025; Kingdom of Saudi Arabia was the largest region with 88%.
Figures from company filings; latest fiscal year ended December 31, 2025.
No profile data available.